1
|
Rommens OA, Kolkman WF, van Wijngaarden P. Mycobacterium wolinskyi infection after breast augmentation: A case report and comprehensive review. IJID REGIONS 2024; 11:100378. [PMID: 38947736 PMCID: PMC11214365 DOI: 10.1016/j.ijregi.2024.100378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 03/23/2024] [Accepted: 05/06/2024] [Indexed: 07/02/2024]
Abstract
We present a case report about a 26-year-old female with a Mycobacterium wolinskyi surgical site infection after bilateral breast augmentation. In a unique approach compared with previously reported cases, the patient was successfully treated in an outpatient setting using only orally administered cotrimoxazole (trimethoprim-sulfamethoxazole) and ciprofloxacin with one-sided preservation of the breast prothesis. We also provide a comprehensive overview of all report cases of M. wolinskyi infections available in the PubMed database until December 2023 and compare the different diagnostic and therapeutic approaches.
Collapse
Affiliation(s)
- Oscar A. Rommens
- Department of Internal Medicine, Amphia Hospital, Breda, Netherlands
- Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium
| | | | | |
Collapse
|
2
|
Holleb P, De S, Antony S. Mycobacterium flavescens Infection - An Unusual Case of Prosthetic Joint Infection. Infect Disord Drug Targets 2024; 24:e170124225744. [PMID: 38314682 DOI: 10.2174/0118715265274138231229070757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Revised: 11/09/2023] [Accepted: 12/04/2023] [Indexed: 02/06/2024]
Abstract
INTRODUCTION The onset of prosthetic joint infections (PJIs) is characterized by early onset defined as within 90 days of the procedure, delayed onset defined as within 3 to 12 months, and late onset defined as over 12 months. In only a scant number of case reports, Mycobacterium flavescens associated infections are typically found in sputum cultures and associated with various forms of penetrating joint traumas, particularly post-surgical interventions. Due to its rarity in presentation among cases of PJIs, we have presented a case of PJI caused by Mycobacterium flavescens. CASE PRESENTATION We have, herein, reported a case of a 70-year-old male presenting with stabbing left knee pain over the past several months along with accompanying erythema and swelling with the presence of purulent discharge. Outpatient cultures have shown the growth of Mycobacterium flavescent; subsequently, the patient underwent a 2-stage revision arthroplasty and was treated with a three-drug regimen and implant 5 months later. Although being an atypical cause of PJIs, we emphasize the importance of considering NTM as a differential for immunocompromised patients, especially those with prior surgical intervention. DISCUSSION Mycobacterium spp. related PJIs manifest clinical features similar to other bacteriacausing PJIs, such as warm, indurated edema at the surgical site resulting in wound dehiscence and joint effusion. Diagnosis of Mycobacterium spp. related PJIs includes history and physical examination findings, serum inflammatory markers, synovial fluid analysis, and culture. Concurrently with surgical interventions, utilization of antimicrobial agents provides additional control in Mycobacterium- related PJI. Mycobacterium flavescens should be included among other NTMs as a possible cause of PJIs.
Collapse
Affiliation(s)
- Peter Holleb
- Department of Internal Medicine, Las Palmas Del Sol Medical Center, El Paso, TX, USA
| | - Srijisnu De
- Department of Internal Medicine, Las Palmas Del Sol Medical Center, El Paso, TX, USA
| | - Suresh Antony
- Department of Internal Medicine, Las Palmas Del Sol Medical Center, El Paso, TX, USA
| |
Collapse
|
3
|
Santoso A, Phatama KY, Rhatomy S, Budhiparama NC. Prosthetic joint infection of the hip and knee due to Mycobacterium species: A systematic review. World J Orthop 2022; 13:503-514. [PMID: 35633748 PMCID: PMC9125004 DOI: 10.5312/wjo.v13.i5.503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2021] [Revised: 11/07/2021] [Accepted: 04/21/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Mycobacterium species (Mycobacterium sp) is an emerging cause of hip and knee prosthetic joint infection (PJI), and different species of this organism may be responsible for the same.
AIM To evaluate the profile of hip and knee Mycobacterium PJI cases as published in the past 30 years.
METHODS A literature search was performed in PubMed using the MeSH terms “Prosthesis joint infection” AND “Mycobacterium” for studies with publication dates from January 1, 1990, to May 30, 2021. To avoid missing any study, another search was performed with the terms “Arthroplasty infection” AND “Mycobacterium” in the same period as the previous search. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses chart was used to evaluate the included studies for further review. In total, 51 studies were included for further evaluation of the cases, type of pathogen, and treatment of PJI caused by Mycobacterium sp.
RESULTS Seventeen identified Mycobacterium sp were reportedly responsible for hip/knee PJI in 115 hip/knee PJI cases, whereas in two cases there was no mention of any specific Mycobacterium sp. Mycobacterium tuberculosis (M. tuberculosis) was detected in 50/115 (43.3%) of the cases. Nontuberculous mycobacteria (NTM) included M. fortuitum (26/115, 22.6%), M. abscessus (10/115, 8.6%), M. chelonae (8/115, 6.9%), and M. bovis (8/115, 6.9%). Majority of the cases (82/114, 71.9%) had an onset of infection > 3 mo after the index surgery, while in 24.6% (28/114) the disease had an onset in ≤ 3 mo. Incidental intraoperative PJI diagnosis was made in 4 cases (3.5%). Overall, prosthesis removal was needed in 77.8% (84/108) of the cases to treat the infection. Overall infection rate was controlled in 88/102 (86.3%) patients with Mycobacterium PJI. Persistent infection occurred in 10/108 (9.8%) patients, while 4/108 (3.9%) patients died due to the infection.
CONCLUSION At least 17 Mycobacterium sp can be responsible for hip/knee PJI. Although M. tuberculosis is the most common causal pathogen, NTM should be considered as an emerging cause of hip/knee PJI.
Collapse
Affiliation(s)
- Asep Santoso
- Department of Orthopaedic and Traumatology, Universitas Sebelas Maret, Surakarta and Prof. Dr. R. Soeharso Orthopaedic Hospital, Sukoharjo 57162, Indonesia
| | - Krisna Yuarno Phatama
- Department of Orthopaedic and Traumatology, Universitas Brawijaya, Saiful Anwar General Hospital, Malang 65112, Indonesia
| | - Sholahuddin Rhatomy
- Department of Orthopaedic and Traumatology, Universitas Gadjah Mada, Yogyakarta and Dr. Soeradji Tirtonegoro General Hospital, Klaten 57424, Indonesia
| | - Nicolaas Cyrillus Budhiparama
- Nicolaas Institute of Constructive Orthopaedic Research and Education Foundation at Medistra Hospital, Jakarta 12950, Indonesia
- Faculty of Medicine, Universitas Airlangga, Jawa Timur 60132, Indonesia
- Department of Orthopaedics, Leiden University Medical Center, Leiden 2333, Netherlands
| |
Collapse
|
4
|
Kitajima H, Oba Y, Ohira T, Asaoka T, Atsumi Y, Nakajima T, Okura T. First case report of prosthetic valve endocarditis caused by Mycobacterium wolinskyi. J Infect Chemother 2021; 27:766-769. [PMID: 33402304 DOI: 10.1016/j.jiac.2020.12.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Revised: 11/14/2020] [Accepted: 12/18/2020] [Indexed: 11/29/2022]
Abstract
To date, only 26 cases of Mycobacterium wolinskyi infections have been reported in humans. We herein report a first case of prosthetic valve endocarditis due to this organism after cardiovascular surgery. An 82-year-old man presented with repeat episodes of syncope and fever after aortic valve replacement, mitral valve replacement, left atrial appendage closure, and pulmonary vein isolation. Blood cultures maintained in aerobic bottles were repeatedly positive after 90-100 hours, and Gallium scan revealed abnormal accumulations in the sternum and left testis. While colonies formed by culturing the fluid of the parasternal area and blood cultures revealed gram-positive rods, we could not analyze the colony using matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF). M. wolinskyi was finally identified on 16S rRNA, hsp65, and rpoB gene sequencing. We treated the patient with multiple antimycobacterial drugs, i.e., amikacin, imipenem, and clarithromycin for 6 weeks, which was changed to oral ciprofloxacin and minocycline for 12 months. This case highlights the need to consider rapidly growing mycobacteria, including M. wolinskyi, if chronic fever persists from weeks to months after surgery, the blood culture is positive, and the organism is not identified. In addition, sequencing the 16S rRNA, hsp65, and rpoB genes is essential for diagnosis.
Collapse
Affiliation(s)
- Heita Kitajima
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan.
| | - Yuichiro Oba
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| | - Takahisa Ohira
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| | - Tomohiro Asaoka
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| | - Yoshihiro Atsumi
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| | - Takahiro Nakajima
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| | - Takayuki Okura
- Department of General Medicine, Osaka General Medical Center, 3-1-56, Sumiyoshi Bandaihigashi, Osaka, 558-8558, Japan
| |
Collapse
|
5
|
Fujikura H, Kasahara K, Ogawa Y, Hirai N, Yoshii S, Yoshihara S, Ogawa T, Yonekawa S, Imakita N, Nishioka Y, Yoneda T, Yoshida K, Samejima KI, Tanabe K, Saito Y, Yano H, Mikasa K. Mycobacterium wolinskyi Peritonitis after Peritoneal Catheter Embedment Surgery. Intern Med 2017; 56:3097-3101. [PMID: 28943571 PMCID: PMC5725868 DOI: 10.2169/internalmedicine.8871-17] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
Mycobacterium wolinskyi belongs to the Mycobacterium smegmatis group, which comprises rapidly growing non-tuberculous mycobacteria. The number of case reports on M. wolinskyi infections associated with postoperative wounds has increased in recent years. We herein report a case of peritonitis due to M. wolinskyi after peritoneal catheter embedment surgery. Identification was achieved based on 16S ribosomal RNA and rpoB gene sequencing of the isolate. The patient recovered following catheter removal and treatment with levofloxacin and minocycline for one month.
Collapse
Affiliation(s)
| | - Kei Kasahara
- Center for Infectious Diseases, Nara Medical University, Japan
| | - Yoshihiko Ogawa
- Center for Infectious Diseases, Nara Medical University, Japan
| | - Nobuyasu Hirai
- Center for Infectious Diseases, Nara Medical University, Japan
| | - Seiya Yoshii
- Center for Infectious Diseases, Nara Medical University, Japan
| | | | - Taku Ogawa
- Center for Infectious Diseases, Nara Medical University, Japan
| | | | - Natsuko Imakita
- Center for Infectious Diseases, Nara Medical University, Japan
| | - Yuichi Nishioka
- Center for Infectious Diseases, Nara Medical University, Japan
| | - Tatsuo Yoneda
- Department of Urology, Nara Medical University, Japan
| | | | - Ken-Ichi Samejima
- First Department of Internal Medicine, Nara Medical University, Japan
| | - Kaori Tanabe
- First Department of Internal Medicine, Nara Medical University, Japan
| | - Yoshihiko Saito
- First Department of Internal Medicine, Nara Medical University, Japan
| | - Hisakazu Yano
- Department of Microbiology and Infectious Diseases, Nara Medical University, Japan
| | - Keiichi Mikasa
- Center for Infectious Diseases, Nara Medical University, Japan
| |
Collapse
|
6
|
Draft Genome Sequence of Mycobacterium wolinskyi, a Rapid-Growing Species of Nontuberculous Mycobacteria. GENOME ANNOUNCEMENTS 2016; 4:4/2/e00138-16. [PMID: 26988052 PMCID: PMC4796131 DOI: 10.1128/genomea.00138-16] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Mycobacterium wolinskyi is a nonpigmented, rapidly growing nontuberculous mycobacterium species that is associated with bacteremia, peritonitis, infections associated with implants/prostheses, and skin and soft tissue infections often following surgical procedures in humans. Here, we report the first functionally annotated draft genome sequence of M. wolinskyi CDC_01.
Collapse
|
7
|
Yoo SJ, Lee KH, Jung SN, Heo ST. Facial skin and soft tissue infection caused by Mycobacterium wolinskyi associated with cosmetic procedures. BMC Infect Dis 2013; 13:479. [PMID: 24131522 PMCID: PMC3852821 DOI: 10.1186/1471-2334-13-479] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2013] [Accepted: 10/10/2013] [Indexed: 12/18/2022] Open
Abstract
Background Mycobacteirum wolinskyi is a member of the Mycobacterium smegmatis group, which is less frequently found in clinical settings than other nontuberculous mycobacterium (NTM) species. However, its clinical significance has recently increased in opportunistic infections. This case is the first report of facial skin and soft tissue infection by M. wolinskyi complicating cosmetic procedures. Case presentation A 56-year-old Asian female patient with a history of receiving multiple facial cosmetic procedures over the preceding 2 years was admitted to our institution with swelling, local pain, and erythema on the right cheek. Mycobacteirum fortuitum complex isolated from a pus culture was identified as M. wolinskyi by rpoB sequencing. Metallic foreign bodies and abscess were detected by radiologic imaging. The pus was incised and drained. Treatment comprised clarithromycin (500 mg every 12 h), amikacin (200 mg every 8 h), and ciprofloxacin (400 mg every 6 h). Conclusion We report the first case of facial skin and soft tissue infection with M. wolinskyi after multiple cosmetic procedures of filler injection and laser lipolysis. Increased occurrence of NTM infection in nosocomial settings suggests the importance of appropriate treatment including culturing and rpoB gene sequencing when patients who have undergone cosmetic procedures display symptoms and signs of soft tissue infection indicative of NTM infection.
Collapse
Affiliation(s)
| | | | | | - Sang Taek Heo
- Department of Infectious Disease, Jeju National University School of Medicine, Jeju-si, Jeju, South Korea.
| |
Collapse
|
8
|
Santos Lima A, Carneiro Neves MM, Machado Gomes K, Miranda Guarines K, Luna CF, Silva Duarte R, Lapa Montenegro LM, Charifker Schindler H. First case report of infection by Mycobacterium wolinskyi after mammoplasty in Brazil. Infect Dis Rep 2013; 5:e12. [PMID: 24470962 PMCID: PMC3892610 DOI: 10.4081/idr.2013.e12] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2013] [Revised: 09/09/2013] [Accepted: 09/28/2013] [Indexed: 11/30/2022] Open
Abstract
Mycobacterium wolinskyi is a rapidly growing mycobacterium, first described in 1999 as a member of the group Mycobacterium smegmatis (Mycobacterium smegmatis, Mycobacterium wolinskyi and Mycobacterium goodii). Only 19 case reports all over the world have been described on literature, none of them in Brazil. On this report, it is described one case of infection after a mammoplasty procedure performed in a private health service in the county of Recife, Pernambuco, Brazil, in 2009. The mycobacteria specie was identified using biochemical tests and sequencing the specific gene rpoB. To treat the infection by Mycobacterium wolinskyi it was necessary to combine antibiotics for a long period of time associated with surgical procedures of the breast abscesses.
Collapse
Affiliation(s)
- Andrea Santos Lima
- Department of Immunology, Aggeu Magalhães Center for Research/Fiocruz , Recif
| | | | - Karen Machado Gomes
- Institute of Microbiology, Federal University of Rio de Janeiro , Recif, Brazil
| | | | - Carlos Feitosa Luna
- Department of Public Health, Aggeu Magalhães Center for Research/Fiocruz , Recif, Brazil
| | - Rafael Silva Duarte
- Institute of Microbiology, Federal University of Rio de Janeiro , Recif, Brazil
| | | | | |
Collapse
|